Predicted protein targets (top 16)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | APP | P05067 | 1/20 | 0.37 |
| ▸ | MCHR1 | Q99705 | 1/20 | 0.35 |
| ▸ | CA1 | P00915 | 1/20 | 0.33 |
| ▸ | CA2 | P00918 | 1/20 | 0.33 |
| ▸ | CA7 | P43166 | 1/20 | 0.33 |
| ▸ | CA9 | Q16790 | 1/20 | 0.33 |
| ▸ | CTSA | P10619 | 1/20 | 0.33 |
| ▸ | THRB | P10828 | 1/20 | 0.33 |
| ▸ | SMN1; SMN2 | Q16637 | 1/20 | 0.33 |
| ▸ | NPSR1 | Q6W5P4 | 1/20 | 0.32 |
| ▸ | AURKA | O14965 | 1/20 | 0.32 |
| ▸ | CSF1R | P07333 | 1/20 | 0.32 |
| ▸ | RET | P07949 | 1/20 | 0.32 |
| ▸ | FLT3 | P36888 | 1/20 | 0.32 |
| ▸ | EGFR | P00533 | 1/20 | 0.32 |
| ▸ | PRKCI | P41743 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL14225430 | 0.90 | CA1 (0.39) | APPMCHR1CA1CA2CA7 | |
| SCHEMBL18165379 | 0.89 | CA1 (0.38) | APPMCHR1CA1CA2CA7 | |
| SCHEMBL17431904 | 0.89 | CA1 (0.38) | APPMCHR1CA1CA2CA7 | |
| SCHEMBL14225434 | 0.89 | CA1 (0.38) | APPMCHR1CA1CA2CA7 | |
| SCHEMBL17431946 | 0.89 | CA1 (0.38) | APPMCHR1CA1CA2CA7 | |
| SCHEMBL14225415 | 0.87 | APP (0.47) | APPMCHR1CA1CA2CA7 | |
| SCHEMBL14225431 | 0.85 | APP (0.46) | APPMCHR1CA1CA2CA7 | |
| SCHEMBL14225418 | 0.85 | APP (0.46) | APPMCHR1CA1CA2CA7 | |
| SCHEMBL19521918 | 0.85 | APP (0.46) | APPMCHR1CA1CA2CA7 | |
| SCHEMBL17431888 | 0.83 | CA1 (0.35) | MCHR1CA1CA2CA7CA9 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-9969931-B2 | Electrochromic composition and electrochromic element | CANON KABUSHIKI KAISHA (JP) | 2018-05-15 | — | — | US | disclosed |
| US-9969931-B2 | Electrochromic composition and electrochromic element | CANON KABUSHIKI KAISHA (JP) | 2018-05-15 | — | — | US | disclosed |
| US-20170114274-A1 | ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2017-04-27 | — | — | US | disclosed |
| US-20170114274-A1 | ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2017-04-27 | — | — | US | disclosed |
| WO-2016006204-A1 | ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT | CANON KABUSHIKI KAISHA (JP) | 2016-01-14 | — | — | WO | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20170114274-A1 | ELECTROCHROMIC COMPOSITION AND ELECTROCHROMIC ELEMENT | SCN11A, ECH1, H1-0 | APP 2275/4885MCHR1 1182/4885CA1 140/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.